Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019282007> ?p ?o ?g. }
- W2019282007 endingPage "1394" @default.
- W2019282007 startingPage "1387" @default.
- W2019282007 abstract "1 The contractile effects of the novel cardiotonic agent HN-10200 (2-[3-methoxy-5-methylsulphinyl-2-thienyl]-1H-imidazo-[4,5-c]-pyridine hydrochloride), were examined and comparisons made with the responses obtained to a structurally similar compound, sulmazole, and to a number of other compounds which are known to inhibit phosphodiesterase (PDE) isoenzymes with differing selectivities; namely, enoximone (PDE III inhibitor), Ro 20–1724 (PDE IV inhibitor) and 3-isobutyl-1-methylxanthine (non-selective PDE inhibitor). 2 Contractile function, as measured by mechanical shortening, and biochemical systems involving cyclic AMP were investigated in ventricular cardiomyocytes isolated from adult Sprague-Dawley rats (200–250 g). 3 HN-10200 exerted a concentration-dependent (10−8 m − 10−4 m) positive contractile effect, which was independent of α- or β-adrenoceptor, or histamine receptor stimulation. 4 The efficacies of the contractile responses to the PDE inhibitors were of the order: HN-10200 > IBMX > sulmazole > enoximone and maximum stimulations, which were obtained at concentrations of 10−4 m, were 54 ± 4%, 41 ± 7%, 38 ± 7% and 26 ± 5% (mean ± s.e.) greater than basal levels, respectively (n = 6); the basal value of contractile amplitude (dL), in the absence of PDE inhibitors was 7.39 ± 0.18% (mean ± s.e.). Ro 20–1724 did not have any effect on contractile activity. 5 Due to low basal levels of cyclic nucleotides in isolated cells, accumulation of cyclic AMP due to the presence of the PDE inhibitors was detected only when the levels of cyclic nucleotide were enhanced with forskolin (10 μm). 6 The PDE inhibitors increased levels of cyclic AMP only at concentrations > 10−4 m. HN-10200 and sulmazole had similar concentration-dependent profiles for the accumulation of cyclic AMP; their potencies were lower than that of IBMX (concentrations of forskolin required to increase cyclic AMP by 4 pmol mg−1 protein, in the presence of maximum concentrations of the PDE inhibitors, were 13 ± 3 μm, 14 ± 3 μm and 3 ± 0.6 μm [mean ± s.e.], respectively). 7 These results indicate that a similar mechanism, probably through a weak inhibition of the cyclic AMP-specific PDE isoenzymes, is responsible for the increase in levels of cyclic AMP by HN-10200 and sulmazole. However, cyclic AMP is only partially responsible for the positive contractile effect of HN-10200 and, similarly, sulmazole and IBMX. The lack of apparent increase in levels of cyclic AMP by enoximone, highlights its degree of selectivity for the PDE III isoenzyme, such that the PDE IV isoform is still present in sufficient quantity to degrade cyclic AMP within the cell. On the other hand, the potent action of Ro 20–1724 on accumulation of cyclic AMP, in addition to the lack of effect on contractile function, is in agreement with the selectivity of this compound for the PDE IV isoenzyme and compartmentalization of cyclic AMP in rat isolated ventricular cardiomyocytes." @default.
- W2019282007 created "2016-06-24" @default.
- W2019282007 creator A5022597113 @default.
- W2019282007 creator A5031151405 @default.
- W2019282007 creator A5062328963 @default.
- W2019282007 date "1993-12-01" @default.
- W2019282007 modified "2023-09-26" @default.
- W2019282007 title "Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes" @default.
- W2019282007 cites W1486274077 @default.
- W2019282007 cites W1576014737 @default.
- W2019282007 cites W1593151186 @default.
- W2019282007 cites W1775749144 @default.
- W2019282007 cites W1856628485 @default.
- W2019282007 cites W187129005 @default.
- W2019282007 cites W1934495609 @default.
- W2019282007 cites W1968133040 @default.
- W2019282007 cites W1970106332 @default.
- W2019282007 cites W1971160638 @default.
- W2019282007 cites W1975219777 @default.
- W2019282007 cites W1976187561 @default.
- W2019282007 cites W1981474413 @default.
- W2019282007 cites W1986199161 @default.
- W2019282007 cites W1995368047 @default.
- W2019282007 cites W1996214634 @default.
- W2019282007 cites W2000536017 @default.
- W2019282007 cites W2003545109 @default.
- W2019282007 cites W2006446901 @default.
- W2019282007 cites W2007414194 @default.
- W2019282007 cites W2009888365 @default.
- W2019282007 cites W2013288686 @default.
- W2019282007 cites W2016659590 @default.
- W2019282007 cites W2018933320 @default.
- W2019282007 cites W2027047679 @default.
- W2019282007 cites W2029899049 @default.
- W2019282007 cites W2029912899 @default.
- W2019282007 cites W2030119770 @default.
- W2019282007 cites W2037397160 @default.
- W2019282007 cites W2045674210 @default.
- W2019282007 cites W2045784400 @default.
- W2019282007 cites W2045978620 @default.
- W2019282007 cites W2052327171 @default.
- W2019282007 cites W2053838253 @default.
- W2019282007 cites W2054050959 @default.
- W2019282007 cites W2054853296 @default.
- W2019282007 cites W2059738075 @default.
- W2019282007 cites W2069570737 @default.
- W2019282007 cites W2071331983 @default.
- W2019282007 cites W2076696870 @default.
- W2019282007 cites W2078626661 @default.
- W2019282007 cites W2084535679 @default.
- W2019282007 cites W2085414181 @default.
- W2019282007 cites W2089352351 @default.
- W2019282007 cites W2089693058 @default.
- W2019282007 cites W2098390405 @default.
- W2019282007 cites W2106606938 @default.
- W2019282007 cites W2122423123 @default.
- W2019282007 cites W2130381329 @default.
- W2019282007 cites W2136154990 @default.
- W2019282007 cites W2155047704 @default.
- W2019282007 cites W2197794443 @default.
- W2019282007 cites W2282653355 @default.
- W2019282007 cites W2328966774 @default.
- W2019282007 cites W2340041051 @default.
- W2019282007 cites W2402834728 @default.
- W2019282007 cites W2417263156 @default.
- W2019282007 cites W2439633225 @default.
- W2019282007 cites W40308862 @default.
- W2019282007 cites W4237719183 @default.
- W2019282007 cites W4246720753 @default.
- W2019282007 cites W4290366835 @default.
- W2019282007 cites W129234738 @default.
- W2019282007 doi "https://doi.org/10.1111/j.1476-5381.1993.tb13974.x" @default.
- W2019282007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2175870" @default.
- W2019282007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8306078" @default.
- W2019282007 hasPublicationYear "1993" @default.
- W2019282007 type Work @default.
- W2019282007 sameAs 2019282007 @default.
- W2019282007 citedByCount "14" @default.
- W2019282007 crossrefType "journal-article" @default.
- W2019282007 hasAuthorship W2019282007A5022597113 @default.
- W2019282007 hasAuthorship W2019282007A5031151405 @default.
- W2019282007 hasAuthorship W2019282007A5062328963 @default.
- W2019282007 hasBestOaLocation W20192820071 @default.
- W2019282007 hasConcept C104317684 @default.
- W2019282007 hasConcept C120770815 @default.
- W2019282007 hasConcept C126322002 @default.
- W2019282007 hasConcept C134018914 @default.
- W2019282007 hasConcept C155710745 @default.
- W2019282007 hasConcept C181199279 @default.
- W2019282007 hasConcept C185592680 @default.
- W2019282007 hasConcept C24998067 @default.
- W2019282007 hasConcept C2776645727 @default.
- W2019282007 hasConcept C2776766087 @default.
- W2019282007 hasConcept C2778024521 @default.
- W2019282007 hasConcept C2778524494 @default.
- W2019282007 hasConcept C2779276759 @default.
- W2019282007 hasConcept C2779306644 @default.
- W2019282007 hasConcept C2780215583 @default.